{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:45:36Z","timestamp":1790635536031,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.annepidem.2020.07.017","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T21:56:24Z","timestamp":1596578184000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Severity score for predicting in-facility Ebola treatment outcome"],"prefix":"10.1016","volume":"49","author":[{"given":"Jia Bainga","family":"Kangbai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foday","family":"Sahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Froeschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2020.07.017_bib1","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of filoviral hemorrhagic fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/004947506775598914","article-title":"A\u00a0clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa","volume":"36","author":"Jeffs","year":"2006","journal-title":"Trop Doct"},{"key":"10.1016\/j.annepidem.2020.07.017_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMsr1513109","article-title":"After Ebola in West Africa \u2014 Unpredictable Risks, Preventable Epidemics","volume":"375","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annepidem.2020.07.017_bib4","series-title":"[November 30, 2014] Outbreaks chronology: Ebola virus disease","year":"2014"},{"issue":"16","key":"10.1016\/j.annepidem.2020.07.017_bib5","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1073\/pnas.1518587113","article-title":"Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone","volume":"113","author":"Fang","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.annepidem.2020.07.017_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S1473-3099(15)00137-1","article-title":"Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study","volume":"15","author":"Lado","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib7","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/infdis\/jiv304","article-title":"The Contribution of Ebola viral load at admission and other patient characteristics to mortality in a M\u00e9decins Sans Fronti\u00e8res Ebola case management centre, Kailahun, Sierra Leone, June\u2013October 2014","volume":"212","author":"Fitzpatrick","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S1473-3099(15)00144-9","article-title":"Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study","volume":"15","author":"Hunt","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team. Clinical illness and outcomes in patients with Ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annepidem.2020.07.017_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10096-015-2457-z","article-title":"Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak","volume":"34","author":"Yan","year":"2015","journal-title":"Eur J Clinmicrobiol Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldman","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2020.07.017_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cll.2009.12.001","article-title":"Ebola and Marburg hemorrhagic fever","volume":"30","author":"Hartman","year":"2010","journal-title":"Clin Lab Med"},{"issue":"2","key":"10.1016\/j.annepidem.2020.07.017_bib13","first-page":"60","article-title":"Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations","volume":"1","author":"Mupere","year":"2001","journal-title":"Afr Health Sci"},{"issue":"7","key":"10.1016\/j.annepidem.2020.07.017_bib14","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2214-109X(16)30097-3","article-title":"Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study","volume":"4","author":"Shah","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.annepidem.2020.07.017_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/cid\/civ319","article-title":"Clinical features of patients with Ebola virus disease in Sierra Leone","volume":"61","author":"Qin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib16","first-page":"1683","article-title":"Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease","volume":"10","author":"McElroy","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annepidem.2020.07.017_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3201\/eid2202.151250","article-title":"Prognostic indicators for Ebola patient survival","volume":"22","author":"Crowe","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3855\/jidc.6484","article-title":"Descriptive analyses and risk of death due to Ebola virus disease, West Africa, 2014","volume":"9","author":"Fasina","year":"2015","journal-title":"J\u00a0Infect Dev Ctries"},{"key":"10.1016\/j.annepidem.2020.07.017_bib20","first-page":"1485","article-title":"Ebola virus disease in West Africa\u2014the first 9 months of the epidemic and forward projections","volume":"371","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annepidem.2020.07.017_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s11427-014-4746-7","article-title":"Fighting Ebola with ZMapp: spotlight on plant-made antibody","volume":"57","author":"Zhang","year":"2014","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.annepidem.2020.07.017_bib22","doi-asserted-by":"crossref","first-page":"e0162199","DOI":"10.1371\/journal.pone.0162199","article-title":"Experimental treatment of Ebola virus disease with brincidofovir","volume":"11","author":"Dunning","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2020.07.017_bib23","doi-asserted-by":"crossref","first-page":"e1001997","DOI":"10.1371\/journal.pmed.1001997","article-title":"Experimental treatment of Ebola virus disease with TKM-130803: a single-Arm phase 2 clinical trial","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.annepidem.2020.07.017_bib24","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): A historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med"},{"issue":"suppl_5","key":"10.1016\/j.annepidem.2020.07.017_bib25","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1093\/infdis\/jiy333","article-title":"Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures","volume":"218","author":"Cagigi","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in guinea","volume":"374","author":"van","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.annepidem.2020.07.017_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/INF.0000000000000707","volume":"34","author":"Kourtis","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.annepidem.2020.07.017_bib28","article-title":"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis","volume":"72","author":"Goeijenbier","year":"2014","journal-title":"J\u00a0Med"},{"issue":"5","key":"10.1016\/j.annepidem.2020.07.017_bib29","doi-asserted-by":"crossref","first-page":"e0176692","DOI":"10.1371\/journal.pone.0176692","article-title":"Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014\u00b115","volume":"12","author":"Theocharopoulos","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2020.07.017_bib30","series-title":"Clinical management of patients with viral haemorrhagic fever: a pocket guide for front line health worker","year":"2014"},{"key":"10.1016\/j.annepidem.2020.07.017_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.medmal.2014.09.009","article-title":"Ebola outbreak in Conakry, Guinea: Epidemiological, clinical and outcome features","author":"Barry","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.annepidem.2020.07.017_bib32","series-title":"Microsoft. Microsoft Word. Redmond","year":"2018"},{"key":"10.1016\/j.annepidem.2020.07.017_bib33","series-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2017","author":"Team","year":"2017"},{"issue":"2","key":"10.1016\/j.annepidem.2020.07.017_bib34","doi-asserted-by":"crossref","first-page":"e0005265","DOI":"10.1371\/journal.pntd.0005265","article-title":"Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease","volume":"11","author":"Hartley","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib35","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.annepidem.2020.07.017_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.micinf.2014.11.007","article-title":"Ebola virus disease: a highly fatal infectious disease reemerging in West Africa","volume":"17","author":"To","year":"2015","journal-title":"Microbes Infect\/Inst Pasteur"},{"issue":"10","key":"10.1016\/j.annepidem.2020.07.017_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal Zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.annepidem.2020.07.017_bib38","doi-asserted-by":"crossref","first-page":"g7348","DOI":"10.1136\/bmj.g7348","article-title":"Ebola virus disease","volume":"349","author":"Beeching","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.annepidem.2020.07.017_bib39","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMp1413084","article-title":"Ebola virus disease in West Africa\u2014clinical manifestations and management","volume":"371","author":"Chertow","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279720302775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279720302775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:26:04Z","timestamp":1760927164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279720302775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"alternative-id":["S1047279720302775"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2020.07.017","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severity score for predicting in-facility Ebola treatment outcome","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2020.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}